Suppr超能文献

一例通过手术治疗和化疗实现长期生存的产甲胎蛋白胃癌晚期复发病例。

A case of a long-term survival achieved by surgical treatment and chemotherapy for late recurrence of AFP-producing gastric cancer.

作者信息

Harada Manabu, Tsujimoto Hironori, Ichikura Takashi, Nagata Hiromi, Ito Nozomi, Nomura Shinsuke, Horiguchi Hiroyuki, Yaguchi Yoshihisa, Kishi Yoji, Ueno Hideki

机构信息

Department of Surgery, National Defense Medical College, 3-2 Namiki, Tokorozawa, Saitama, 359-8513, Japan.

出版信息

Surg Case Rep. 2019 Jul 1;5(1):106. doi: 10.1186/s40792-019-0664-z.

Abstract

BACKGROUND

Alpha-fetoprotein-producing gastric cancer (AFP-GC) is a relatively rare disease, with a dismal prognosis.

CASE PRESENTATION

We report the case of a patient with long-term survival after surgery for the recurrence of AFP-GC. A 71-year-old man was diagnosed with gastric cancer and underwent distal gastrectomy with D2 lymphadenectomy (pT3N2M0). Pathological examination of the resected specimen revealed AFP-GC. Fifteen years after the gastrectomy, the patient experienced anorexia and was admitted with a mass located at the mesentery of the small intestine. Following a diagnosis of gastrointestinal stromal tumor of the mesentery, a tumor resection with partial small intestine was performed. The final histopathological diagnosis was AFP-GC's recurrence in the small-bowel mesentery. Two months later, multiple liver metastases were identified, and serum AFP level was found to be extremely high (17,447 ng/mL). Chemotherapy with S-1+CDDP (SP) was initiated for liver metastasis. However, owing to anorexia and fatigue, SP therapy was discontinued following the patient's request at the end of two courses. A CT scan at 1 month after the discontinuation of chemotherapy did not reveal liver metastasis, and serum AFP level decreased to the normal range. He is alive at present with no re-recurrence and no elevation of serum AFP level at 7 years after the second surgery without any chemotherapy.

CONCLUSION

Even if recurrence of AFP-GC is diagnosed, radical resection and chemotherapy are effective, as noted in the present case.

摘要

背景

产甲胎蛋白胃癌(AFP-GC)是一种相对罕见的疾病,预后较差。

病例报告

我们报告一例AFP-GC复发术后长期存活的患者。一名71岁男性被诊断为胃癌,接受了D2淋巴结清扫的远端胃切除术(pT3N2M0)。切除标本的病理检查显示为AFP-GC。胃切除术后15年,患者出现厌食,因小肠系膜处有肿块入院。在诊断为肠系膜胃肠道间质瘤后,进行了小肠部分切除的肿瘤切除术。最终组织病理学诊断为AFP-GC复发于小肠系膜。两个月后,发现多处肝转移,血清甲胎蛋白水平极高(17447 ng/mL)。开始用S-1+顺铂(SP)进行肝转移化疗。然而,由于厌食和疲劳,两个疗程结束后患者要求停止SP治疗。化疗停止1个月后的CT扫描未显示肝转移,血清甲胎蛋白水平降至正常范围。第二次手术后7年,他目前仍存活,未再次复发,血清甲胎蛋白水平未升高,且未接受任何化疗。

结论

如本病例所示,即使诊断为AFP-GC复发,根治性切除和化疗也是有效的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c416/6603113/93ecefa270a1/40792_2019_664_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验